genXone S.A. (WSE: GX1)
Health Care · Biotechnology · PL
zł5.76
-2.37% today · +0.3% 1Y
genXone S.A. (WSE: GX1) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.90M.
Over the last twelve months the share price has gained 0.3%, trading between 3.81 and 6.96.
Tweenvest scores genXone S.A. across four factors: quality 44/100, value 77/100, growth 0/100. Its strongest factor is value.
GX1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.90M
- Revenue (TTM)
- $660.20K
- P/E
- —
- EPS
- -0.66
- Dividend yield
- —
- Beta (5Y)
- -0.33
- 52-week high
- zł6.96
- 52-week low
- zł3.81
- Avg volume (3M)
- —
- Shares outstanding
- 3.30M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Marvel Biosciences Corp.TSXV: MRVL | $5.22M | CA$0.10 | -13.04% |
| AIM ImmunoTech Inc.NYSEAM: AIM | $5.12M | $0.17 | -6.61% |
| Plant Advanced Technologies SAENXTPA: ALPAT | $5.01M | €3.98 | +1.02% |
| Cardio Diagnostics Holdings, Inc.NasdaqCM: CDIO | $5.00M | $1.69 | -9.63% |
| Creative Medical Technology Holdings, Inc.NasdaqCM: CELZ | $4.89M | $0.74 | -11.63% |
| bioAffinity Technologies, Inc.NasdaqCM: BIAF | $4.79M | $3.73 | -21.06% |
| Stem Cells Spin S.A.WSE: SCS | $4.68M | zł0.44 | -10.20% |
| AFC Agro Biotech LimitedDSE: AFCAGRO | $4.67M | Tk5.00 | -12.28% |
Figures last refreshed Oct 18, 2026.